✦ LIBER ✦

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

✍ Scribed by R. Moucari; N. Boyer; M.-P. Ripault; C. Castelnau; V. Mackiewicz; A. Dauvergne; D. Valla; M. Vidaud; M.-H. N. Chanoine; P. Marcellin

Book ID: 108886477
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 193 KB
Volume: 18
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2010.01332.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine/pegylated interferon alfa-2b

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Combination therapy with pegylated inter

Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study

✍ Yu-hua Liu 刘育华,Tao Wu 吴涛,Ning Sun 孙宁… 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 Chinese ⚖ 550 KB

505 EXTENDED PEGYLATED INTERFERON ALFA-2

505 EXTENDED PEGYLATED INTERFERON ALFA-2A THERAPY IN CHINESE PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED OPEN-LABELLED STUDY

✍ X.P. Chen; X.F. Chen; J. Huang; W.L. Chen; R. Chen; X.J. Ma; X.D. Luo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Early serum HBsAg drop: A strong predict

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

✍ Rami Moucari; Vincent Mackiewicz; Olivier Lada; Marie-Pierre Ripault; Corinne Ca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap

[10] THE SAFETY AND EFFICACY OF TARIBAVI

[10] THE SAFETY AND EFFICACY OF TARIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a VERSUS RIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a IN THERAPY-NAIVE PATIENTS INFECTED WITH HCV: PHASE 3 RESULTS

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB